January 19, 2001


Questions for Topic 3

Chronic Wasting Disease, FDA/CFSAN Regulatory Issues, Robert E Brackett PhD, FDA

Elk Industry Perspective on Chronic Wasting Disease, Dr. Zebarth

Position Statement on Chronic Wasting Disease, Mike Kilpatrick, North American Elk Breeders Association

Issue 4.  Potential Exposure of Blood, Plasma & Tissue Donors to Various TSE Agents of Animals

Charge and Questions for Topic 4

Suitability of Blood, Plasma & Tissue Donors Exposed to Various TSE Agents of Animals:  Introduction, Charge and Questions, David M. Asher, MD, FDA

Animal-Derived Dietary Supplement Ingredients, Robert J Moore, PhD, FDA

Comments of the Greater New York Hospital Association, Kenneth E Raske

Comments from Terry S Singletary Sr.

Comments from B Sachau

Statement of America's Blood Centers, Dr Merlyn Sayers, MD, PhD

Statement of Impact from the New York Blood Center, Dr Robert Jones

Tissue Banks International (TBI), Gerald J Cole

Comments from Joseph H Davis MD, Emeritus University of Miami

Comments from Council of Hospital Blood Bank Directors of the Greater New York Region Inc, David L Wuest MD

Testimony of Bess Believeaux, Lions Eye Bank of Central Texas

News Release, American Red Cross Urges Tightened Restructions on Blood Donors Who Resided in Europe

American Red Cross Position Statement to the Transmissible Spongiform Encephalopthy (TSE) Committee

Statement of the American Association of Blood Banks Before the Transmissible Spongiform Encephalopathies Advisory Committee